Evidence map›Paper›PMID 23071680›Full record

ArticlePloS one2012

α6 Integrin and CD44 enrich for a primary keratinocyte population that displays resistance to UV-induced apoptosis.

Helen Wray, Ian C Mackenzie, Alan Storey, Harshad Navsaria

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Helen WrayBlizard Institute of Cell and Molecular Science, Queen Mary's School of Medicine and Dentistry, Whitechapel, London, United Kingdom.
Ian C Mackenzie
Alan Storey
Harshad Navsaria
Queen Mary University of London · GBUniversity of Oxford · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/B/15384Biotechnology and Biological Sciences Research Council C20349
6 · The paper itself

Abstract

Epidermal human keratinocytes are exposed to a wide range of environmental genotoxic insults, including the UV component of solar radiation. Epidermal homeostasis in response to cellular or tissue damage is maintained by a population of keratinocyte stem cells (KSC) that reside in the basal layer of the epithelium. Using cell sorting based on cell-surface markers, we have identified a novel α6 integrin(high+)/CD44(+) sub-population of basal keratinocytes. These α6 integrin(high+)/CD44(+) keratinocytes have both high proliferative potential, form colonies in culture that have characteristics of holoclones and have a unique pattern of resistance to apoptosis induced by UVB radiation or by agents that induce single- or double strand DNA breaks. Resistance to UVB induced apoptosis in the α6 integrin(high+)/CD44(+) cells involved increased expression of TAp63 and was overcome by PI-3 kinase inhibition. In marked contrast, the α6 integrin(high+)/CD44(+) cells were sensitive to apoptosis induced by the cross-linking agent cisplatin, and imatinib inhibition of c-Abl blocked the ability of cisplatin to kill α6 integrin(high+)/CD44(+) cells. Our findings reveal a population of basal keratinocytes with long-term proliferative properties that display specific patterns of apoptotic resistance that is dependent upon the genotoxic stimulus, and provide insights into how these cells can be targeted with chemotherapeutic agents.

Indexed as

Ultraviolet RaysAndrostadienesAntineoplastic AgentsApoptosisBenzamidesCamptothecinCell ProliferationCells, CulturedCisplatinDrug ResistanceEtoposideFluorescent Antibody TechniqueGene ExpressionHumansHyaluronan ReceptorsImatinib MesylateAndrostadienesAntineoplastic AgentsBenzamidesCamptothecinCD44 protein, humanCisplatinEtoposideHyaluronan ReceptorsImatinib MesylateIntegrin alpha6Phosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPiperazinesPyrimidinesTP63 protein, humanTranscription FactorsTumor Suppressor ProteinsWortmannin

Identifiers

PMID23071680
PMCPMC3468583
OpenAlexW2032828298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.